Pharmafile Logo
Pharmafocus logo
Advanced Search

CEO

Showing 14 posts of 59 posts found.

narasimhan_2

Novartis exec designated as new CEO after Jimenez announces retirement

September 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …

Appointment
ludwig_hantson_small

Alexion leadership uncertainty ends as ex-Baxalta CEO steps in

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, CEO

Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …

Appointment
valeant

Hard times continue for Valeant as ex-CEO investigated for fraud

November 1, 2016
Manufacturing and Production CEO, Valeant, Valeant Pharmaceuticals, accounting, fraud

Valeant Pharmaceuticals continues to have a tough time after Bloomsberg broke the story of how former CEO J. Michael Pearson …

News
logo-int-corp2

Concordia founder resigns and will step down once replacement found

October 25, 2016
Manufacturing and Production CEO, Concordia, Mark Thompson, Valeant

Concordia International Corp., the Ontario-based company, has announced that its founder, Chairman and Chief Executive Officer, Mark Thompson, will leave …

News
brent_saunders

Allergan CEO outlines ‘social contract with patients’

September 7, 2016
Research and Development, Sales and Marketing Allergan, Brent Saunders, CEO, blog

Highlighting a recent shift in the priorities of the pharmaceutical industry, Allergan CEO and president Brent Saunders has outlined a …

News
gabriel-baertschi

Grünenthal chief executive Eric-Paul Pâques to retire; new CEO named

June 7, 2016
CEO, Grünenthal Group, appointment

Germany-based Grünenthal Group on Tuesday named Gabriel Baertschi its chief executive officer effective October 1, 2016.  He succeeds Eric-Paul Pâques who will retire at the end of …

Appointment
sanofi_hq__boetie_hall

Sanofi sends letter to Medivation board; claims shareholders want takeover

May 5, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Medivation, Sanofi, board, brandicourt, hostile, shareholders, takeover

The CEO of Sanofi has issued a strongly worded letter to the board at Medivation, indicating that shareholders support their …

News
joseph_papa

Valeant names Joseph Papa as new chief executive officer

April 25, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Chairman, Valeant, joseph papa, new, new ceo, papa, pearson

Valeant Pharmaceuticals has announced that Joseph C. Papa will succeed Michael Pearson as chairman and chief executive officer of the …

Appointment
dollars_medicines

KaloBios announces new affordable pricing model, refuses to engage in “price gouging”

April 12, 2016
Manufacturing and Production, Sales and Marketing CEO, Drug pricing, KaloBios, Martin Shkreli, Shkreli, affordable, price gouging, price model, responsible

Price gouging has become synonymous with drug costs in the US, with the infamous Martin Shkreli and troubled Valeant becoming …

News
lab

Cambridge Epigenetix says raised $21 million, appoints Geoff Smith CEO

March 14, 2016
Business Services, Sales and Marketing CEGX, CEO, Cambridge Epigenetix, fundraising, genome sequencing

Cambridge Epigenetix (CEGX) on Monday said it has raised about $21 million via Series B financing and named Geoff Smith …

News
manmeetsoni

Ariad names Manmeet Soni CFO

March 14, 2016
Business Services, Sales and Marketing Ariad, CEO, appointment, boardroom, cfo

Ariad Pharmaceuticals Inc (Nasdaq: ARIA) named Manmeet Soni chief financial officer, effective March 21, 2016, succeeding Edward Fitzgerald. Mr Soni will …

Appointment
Bayer image

Bayer justifies Brandicourt’s ‘golden handshake’

February 27, 2015
Medical Communications, Sales and Marketing Bayer, CEO, Sanofi, dekkers, olivier brandicourt, payments, wages

Bayer has confirmed that Sanofi’s justification for the controversial starter package it is giving to the German firm’s Olivier Brandicourt …

News

Alzheimer’s drug development ‘must speed up’

November 7, 2013
Research and Development, Sales and Marketing Alzheimer's, CEO, drug development

Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …

News
Novartis image

Novartis recognised for efforts in cancer

August 8, 2013
Medical Communications, Sales and Marketing Bush, CEO, Cancer, Novartis

Novartis is the first company to earn a global CEO Cancer Gold Standard accreditation by the non-profit organisation CEO Roundtable …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026